Notably, key transcription factors involved in ER+ breast cancer were highly enriched, including methylation-sensitive estrogen response elements (EREs) and ELF5 (ETS transcription factor family members), as well as architectural proteins CTCF and ZNF165 (Fig. 4c). The gene discussed is ZNF165; the disease is breast carcinoma.